Chemoinformaics analysis of 23-HYDROXYPHYSALOLACTONE
| Molecular Weight | 555.064 | nRot | 2 |
| Heavy Atom Molecular Weight | 515.752 | nRig | 30 |
| Exact Molecular Weight | 554.228 | nRing | 5 |
| Solubility: LogS | -2.892 | nHRing | 1 |
| Solubility: LogP | 1.552 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 39 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 82.1629 |
| nHD | 6 | BPOL | 43.1071 |
| QED | 0.293 |
| Synth | 5.838 |
| Natural Product Likeliness | 2.298 |
| NR-PPAR-gamma | 0.018 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.132 |
| Pgp-sub | 0.052 |
| HIA | 0.071 |
| CACO-2 | -5.259 |
| MDCK | 0.0000149 |
| BBB | 1 |
| PPB | 0.620217 |
| VDSS | 0.71 |
| FU | 0.388883 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.821 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.056 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.079 |
| CYP3a4-inh | 0.327 |
| CYP3a4-sub | 0.931 |
| CL | 3.156 |
| T12 | 0.129 |
| hERG | 0.025 |
| Ames | 0.019 |
| ROA | 0.997 |
| SkinSen | 0.015 |
| Carcinogencity | 0.31 |
| EI | 0.007 |
| Respiratory | 0.577 |
| NR-Aromatase | 0.95 |
| Antiviral | Yes |
| Prediction | 0.812925 |